Sagimet Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021
Market Capitalization	94	124	-	-
Enterprise Value	-100	29	-32	-56
PE Ratio	-	-4.45	-	-
PS Ratio	46.75	62.05	-	-
PB Ratio	0.49	1.36	-	-
P/FCF Ratio	-7.56	-5.22	-	-
P/OCF Ratio	-7.56	-5.22	-	-
EV/Sales Ratio	-10.35	14.63	-	-
EV/EBITDA Ratio	0.75	-1.06	1.06	2.32
EV/EBIT Ratio	0.74	-1.05	1.05	2.31
EV/FCF Ratio	0.90	-1.23	1.31	2.60
Debt / Equity Ratio	0.00	0.00	0.00	0.00
Debt / EBITDA Ratio	0.00	0.00	-0.01	-0.01
Debt / FCF Ratio	0.00	0.00	-0.01	-0.02
Quick Ratio	42.95	16.78	6.13	23.26
Current Ratio	43.12	17.09	6.21	24.04
Asset Turnover	0.02	0.03	0	-
Return on Equity (ROE)	-61.90%	55.20%	17.70%	-
Return on Assets (ROA)	-26.90%	-44.90%	-66.30%	-
Return on Capital (ROIC)	-17.23%	-33.73%	16.63%	15.02%
Earnings Yield	-29.86%	-22.46%	-	-
FCF Yield	-24.48%	-19.15%	-	-
Buyback Yield / Dilution	-15585.37%	-5565.90%	-50.61%	-
Total Shareholder Return	-15585.37%	-5565.90%	-50.61%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).